PRESS RELEASE / 2019-04-23
Viedoc today announced its partnership with Peking University Clinical Research Institute (PUCRI), a world-renowned academic center dedicated to enhancing the development of high-quality clinical research and health innovation in China.
The partnership will accelerate the adoption of the Viedoc platform across the Chinese clinical research sector and, in doing so, help life sciences companies improve operational efficiencies and increase productivity across China's clinical research programs.
PUCRI has a wide range of partners within the clinical research sector, including government organizations, over 300 hospitals, hundreds of pharmaceutical companies and CROs across the country. As a result of PUCRI’s partnership with Viedoc, the university will be provided with cloud-based EDC technology, served from servers within China.
"We are delighted to initiate a partnership with Viedoc. Being able to store data within China is extremely important for Chinese domestic companies. By working with Viedoc, we look forward to advancing clinical development in China and serving as a bridge between top modern EDC technology and innovative drug development", says Prof Yangfeng Wu at PUCRI.
Yvonne Zhou, Viedoc’s managing director China, says: "This is a collaboration that benefits all parties. Leveraging PUCRI's clinical trial expertise will enable us to serve more life sciences organizations in China and to accelerate drug development, allowing patients to access new therapies faster, both from the local market and around the world."
About Peking University Clinical Research Institute(PUCRI)
Peking University Clinical Research Institute (PUCRI) was founded in 2008, under the direct leadership of Peking University Health Science Center (PUHSC), as the first university-established public platform in China specialized in teaching, research, services, training, organizational coordination and technical support of clinical research. The institute also hosts the Peking University - APEC Regulatory Science Center of Excellence.
PUCRI is committed to improving clinical research in China, to promote the innovation in clinical medicine and hence people's well-being. PUCRI provides technical support to various clinical studies including new drug development, specifically research design, execution, quality management, data management and statistical analysis.
For more information, please contact any of the following:
Yvonne Zhou, Managing Director Viedoc,
John Overend, Global Director of Sales and Marketing Viedoc,
Henrik Blombergsson, Co-founder & COO Viedoc,